Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Koensgen · SciRah

Researcher profile · Semantic Scholar

D. Koensgen

Share profile

D. Koensgen — researcher profile on SciRah

h-index: 17
Works: 74
Citations: 1,596

Most-cited papers

Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.
Steffen Runz, Sascha Keller, C. Rupp, A. Stoeck +6 more
2007Gynecologic Oncology381 citations
Semantic Scholar
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
Sascha Keller, Anne-Kathleen König, F. Marmé, Steffen Runz +5 more
2009Cancer Letters299 citations
Semantic Scholar
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum‐induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
L. Nicholson, PaulR . Smith, L. Hiller, P. Szlosarek +6 more
2009International Journal of Cancer134 citations Open access
Semantic Scholar
Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).
E. Greimel, A. Nordin, A. Lanceley, C. Creutzberg +15 more
2011European Journal of Cancer121 citations
Semantic Scholar
Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.
N. Syed, H. Coley, J. Sehouli, D. Koensgen +8 more
2011Cancer Research62 citations Open access
Semantic Scholar
Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth - A Putative Treatment Option in Ovarian Cancer Therapy.
D. Koensgen, Ilma Besic, Denis Gümbel, A. Kaul +6 more
2017Anticancer Research55 citations Open access
Semantic Scholar
Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
D. Koensgen, A. Mustea, I. Klaman, P. Sun +5 more
2007Gynecologic Oncology54 citations
Semantic Scholar
Heat Shock Protein HSP27 Secretion by Ovarian Cancer Cells Is Linked to Intracellular Expression Levels, Occurs Independently of the Endoplasmic Reticulum Pathway and HSP27's Phosphorylation Status, and Is Mediated by Exosome Liberation
M. Stope, Gerd Klinkmann, K. Diesing, D. Koensgen +2 more
2017Disease Markers38 citations Open access
Semantic Scholar
Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study.
A. Mustea, E. Braicu, D. Koensgen, Shu-Hui Yuan +6 more
2009Cytokine37 citations
Semantic Scholar
Polymorphism of the IL-8 gene and the risk of ovarian cancer.
D. Koensgen, D. Bruennert, S. Ungureanu, D. Sofroni +10 more
2015Cytokine36 citations
Semantic Scholar
Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer.
J. Sehouli, A. Mustea, D. Koensgen, F. Chen +1 more
2003Annals of Oncology29 citations Open access
Semantic Scholar
Plasma Treatment of Ovarian Cancer Cells Mitigates Their Immuno-Modulatory Products Active on THP-1 Monocytes
Sander Bekeschus, Can Pascal Wulf, Eric Freund, D. Koensgen +3 more
2018Plasma24 citations Open access
Semantic Scholar
Jump in the fire--heat shock proteins and their impact on ovarian cancer therapy.
M. Stope, D. Koensgen, Martin Burchardt, N. Concin +2 more
2016Critical reviews in oncology/hematology24 citations
Semantic Scholar
Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.
J. Sehouli, A. Mustea, D. Koensgen, W. Lichtenegger
2003Cancer Epidemiology, Biomarkers and Prevention23 citations
Semantic Scholar
Expression and localization of e-cadherin in epithelial ovarian cancer.
D. Koensgen, Cornelia Freitag, I. Klaman, E. Dahl +5 more
2010Anticancer Research22 citations
Semantic Scholar
New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.
J. Sehouli, D. Koensgen, Gülten Oskay-Ozcelik, A. Mustea
2008Critical reviews in oncology/hematology18 citations
Semantic Scholar
Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald.
D. Koensgen, Martin Weiss, K. Assmann, S. Brucker +3 more
2018Anticancer Research17 citations Open access
Semantic Scholar
Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)
A. Mustea, D. Koensgen, A. Belau, J. Sehouli +10 more
2013Cancer Chemotherapy and Pharmacology17 citations
Semantic Scholar
Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO.
G. Oskay-Oezcelik, D. Koensgen, H. Hindenburg, P. Klare +6 more
2008Anticancer Research16 citations
Semantic Scholar
Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study
D. Koensgen, D. Stengel, A. Belau, P. Klare +10 more
2008Cancer Chemotherapy and Pharmacology15 citations
Semantic Scholar
Overexpression of the plasminogen activator inhibitor type-1 in epithelial ovarian cancer.
D. Koensgen, A. Mustea, C. Denkert, Peng-Ming Sun +2 more
2006Anticancer Research15 citations
Semantic Scholar
Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology
D. Koensgen, J. Sehouli, A. Belau, Martin Weiss +8 more
2016International Journal of Gynecologic Cancer14 citations Open access
Semantic Scholar
The future therapy of endometrial cancer: microRNA’s functionality, capability, and putative clinical application
M. Stope, D. Koensgen, J. Weimer, Madeleine Paditz +3 more
2016Archives of Gynecology and Obstetrics14 citations
Semantic Scholar
The -463G/A polymorphism in myeloperoxidase gene and cervical cancer.
A. Mustea, G. Heinze, J. Sehouli, D. Koensgen +8 more
2007Anticancer Research12 citations
Semantic Scholar
Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network
D. Koensgen, M. Stope, Ivana Tuerbachova, D. Bruennert +9 more
2017Gynecologic and Obstetric Investigation11 citations Open access
Semantic Scholar
Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.
A. Mustea, J. Sehouli, G. Fabjani, D. Koensgen +6 more
2007Anticancer Research11 citations
Semantic Scholar
The Tumor Suppressor MicroRNA-1 Exhibits Restricted Inhibition of Proliferation of Ovarian Cancer Cells.
M. Stope, D. Hettenbach, A. Kaul, Madeleine Paditz +5 more
2016Anticancer Research10 citations
Semantic Scholar
Evaluation of the Diagnostic Potential of Circulating MicroRNAs miR-1 and miR-21 in Patients With Ovarian Cancer
D. Ralser, M. Condic, E. Egger, D. Koensgen +2 more
2022Anticancer Research9 citations
Semantic Scholar
Functionality of the Tumor Suppressor microRNA-1 in Malignant Tissue and Cell Line Cells of Uterine Leiomyosarcoma.
M. Stope, V. Cernat, A. Kaul, K. Diesing +3 more
2018Anticancer Research8 citations Open access
Semantic Scholar
Drug-induced Modulation of Heat Shock Protein HSPB1 in an Ovarian Cancer Cell Model.
M. Stope, Luise Wiegank, Martin Weiss, K. Diesing +4 more
2016Anticancer Research8 citations
Semantic Scholar
Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
A. Mustea, D. Ralser, E. Egger, Ulrike Ziehm +12 more
2023Cancers7 citations Open access
Semantic Scholar
Biweekly schedule of pegylated liposomal doxorubicin (PLD) induces low rates of skin toxicities: Results of a phase-II trial in heavily preteated patients with relapsed ovarian cancer.
J. Sehouli, G. Oskay, I. Katsares, P. Klare +5 more
2004Journal of Clinical Oncology6 citations
Semantic Scholar
Comparison of laparoscopy-assisted vaginal hysterectomy as endoscopic single-station surgery and conventional laparoscopic hysterectomy—surgical effects on safety and quality of life
A. Mustea, B. Holthaus, H. Elmeligy, Stefanie Krüger-Rehberg +7 more
2019Gynecological Surgery5 citations Open access
Semantic Scholar
Development of the Berlin Symptom Checklist Ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II study
D. Koensgen, G. Oskay-Oezcelik, I. Katsares, U. Walle +6 more
2010Supportive Care in Cancer5 citations
Semantic Scholar
Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach
Alexander Mustea, D. Ralser, E. Egger, Ulrike Ziehm +15 more
2024Journal of Cancer Research and Clinical Oncology4 citations Open access
Semantic Scholar
Y-box Binding Protein-1 Enhances Oncogenic Transforming Growth Factor β Signaling in Breast Cancer Cells via Triggering Phospho-Activation of Smad2.
M. Stope, Martin Weiss, D. Koensgen, S. Popp +4 more
2017Anticancer Research4 citations Open access
Semantic Scholar
Expression pattern of the microRNA miR-1 in ovarian cancer cell lines and tumor tissue samples implies a loss of miR-1's tumor suppressor properties
M. Stope, S. Delogu, K. Diesing, Gerd Klinkmann +5 more
20144 citations Open access
Semantic Scholar
Adjuvant sequential chemo-radiation therapy in high-risk endometrial cancer: Results of a prospective, multicenter phase II study of the NOGGO.
D. Koensgen, A. Belau, J. Sehouli, Harald Sommer +11 more
2011Journal of Clinical Oncology4 citations
Semantic Scholar
Tumor- and stromal cell-specific expression of topoisomerase IIα and HER-2/neu in primary and recurrent ovarian cancer: Results of a prospective study.
R. Chekerov, D. Koensgen, I. Klaman, A. Rosenthal +5 more
2009Molecular Medicine Reports4 citations Open access
Semantic Scholar
Biweekly schedule of pegylated liposomal doxorubicin (PLD) induces low rates of skin toxicities: Results of a phase-II trial in heavily preteated patients with relapsed ovarian cancer
J. Sehouli, G. Oskay, I. Katsares, P. Klare +5 more
20044 citations
Semantic Scholar
Robotic-assisted tendon transplantation—approach for pelvic organ prolapse repair: a case report
D. Koensgen, Charlotte Lukannek, Carolin Schroeder, Lucia A. Otten +2 more
2025Journal of Medical Case Reports2 citations Open access
Semantic Scholar
Hypermethylation of N33 (TUSC3) as independent molecular predictor for ovarian cancer
Dietmar Pils, P. Horák, A. Kirisits, A. Gleiss +7 more
20062 citations
Semantic Scholar
Tumour biology in advanced ovarian cancer: Do older patients (>65 years) have other tumour characteristics than younger patients?
D. Koensgen, J. Sehouli, A. Mustea, M. Hauschild +1 more
2004Journal of Clinical Oncology2 citations
Semantic Scholar
Relapsed ovarian cancer after failure of first-line chemotherapy with platin and paclitaxel — a phase II study
J. Sehouli, W. Lichtenegger, G. Oskay, D. Koensgen +6 more
20012 citations
Semantic Scholar
Mesh-sacropexy in women with apical pelvic organ prolapse – results of a single-centre prospective cohort study
C. Schröder, Jakob F. Pantenburg, Laura Tascón Padrón, Karla Feodorovici +5 more
2026BMC Women's Health1 citations Open access
Semantic Scholar
Implementation of Robotic-Assisted Sacrocervicopexy for Apical Organ Prolapse Using the Semitendinosus Tendon—Pilot Study and Analysis of Clinical Outcome
C. Schröder, Charlotte Lukannek, E. Egger, Lucia A. Otten +2 more
2024International Urogynecology Journal1 citations Open access
Semantic Scholar
Bildgebung des Beckenbodens
Teresa Anzböck, D. Koensgen
2023Die Radiologie1 citations Open access
Semantic Scholar
Cold Atmospheric Plasma Suppresses Ovarian Cancer Cell Activity With Concurrent Secretion Of Heat Shock Protein 27 Affecting Monocyte Fate
M. Stope, D. Koensgen, Candace Wulff, Ilma Besic +7 more
20181 citations
Semantic Scholar
Perioperative epidural analgesia and recurrence-free survival for ovarian cancer surgery: A retrospective analysis.
D. Koensgen, A. Mustea, Barbara Rosanowski, B. Leutzow +6 more
20131 citations
Semantic Scholar
Role of multivisceral cytoreductive surgery in patients (pts) with recurrent ovarian cancer (ROC): Who will not benefit from radical tumor debulking?
D. Koensgen, A. Mustea, H. Weidemann, U. Neumann +6 more
20071 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Mustea×40
Invite
A. Mustea — researcher profile on SciRah
J. Sehouli×23
Invite
J. Sehouli — researcher profile on SciRah
M. Stope×17
Invite
M. Stope — researcher profile on SciRah
W. Lichtenegger×13
Invite
W. Lichtenegger — researcher profile on SciRah

×8

Invite

M. Zygmunt — researcher profile on SciRah

Invite

K. Diesing — researcher profile on SciRah

Martin Weiss×6

Invite

Martin Weiss — researcher profile on SciRah

M. Burchardt×6

Invite

M. Burchardt — researcher profile on SciRah

Invite

P. Klare — researcher profile on SciRah

Lucia A. Otten×5

Invite

Lucia A. Otten — researcher profile on SciRah

Invite

A. Kaul — researcher profile on SciRah

Invite

E. Dahl — researcher profile on SciRah